Eli Lilly Gets Green Light to Sell Weight-Loss Drug in China

Key TakeawayEli Lilly announced on its WeChat account Friday that it has won approval from Chinese regulators to sell tirzepatide for weight loss in the country.Tirzepatide is the active ingredient in Lilly’s injectable diabetes treatment Mounjaro and weight-loss drug Zepbound.Novo Nordisk announced in June that its weight-loss drug Wegovy received similar approval in China. Eli Lilly and Co. (LLY) announced on its WeChat account Friday that it has won approval from Chinese regulators to sell tirzepatide fo ...